×

Biotech and Pharmaceuticals Life Sciences

  • Higher spending across the board drove Johnson& Johnson's third-quarter profit down 12 percent, despite a big sales jump fueled by recent acquisitions, hot new cancer drugs and strong sales of other key medicines. "This was a strong quarter for Johnson& Johnson," Edward Jones analyst Ashtyn Evans wrote Tuesday to investors, adding that its strong balance sheet...

  • Oct 16- Aimmune Therapeutics Inc said on Monday it would collaborate with Regeneron Pharmaceuticals Inc and Sanofi to develop its experimental peanut allergy drug. The company said it would test the drug, AR101, in combination with Regeneron and Sanofi's dupilumab in a mid-stage trial that is expected to start in 2018 and will be sponsored by Regeneron.

  • Oct 12- Spark Therapeutics Inc's experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the Food and Drug Administration concluded on Thursday, paving the way for the first U.S. gene therapy for an inherited disease. The FDA is not obliged to follow the recommendations of its advisers but typically does.

  • Oct 12- Spark Therapeutics Inc's experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the Food and Drug Administration concluded on Thursday, paving the way for the first U.S. gene therapy for an inherited disease. The FDA is not obliged to follow the recommendations of its advisers but typically does.

  • SILVER SPRING, Md.— The Latest on an FDA panel's discussion on a gene therapy treatment for blindness:. A panel of experts to the Food and Drug Administration voted unanimously in favor of Spark Therapeutics' injectable therapy, which aims to improve vision in patients with a rare mutation that gradually destroys normal vision. The FDA has until mid-January to...

  • Oct 12- Spark Therapeutics Inc's experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the Food and Drug Administration concluded on Thursday, paving the way for the first U.S. gene therapy for an inherited disease. The panel voted unanimously in favor of the treatment, Luxturna, which is designed to treat...

  • BOSTON, Oct 12- A former Akebia Therapeutics Inc employee accused of insider trading was released from jail on Thursday despite a judge's concern that the man's "Dr. Magistrate Judge Donald Cabell, who ordered Schultz Chan arrested on Sept. 22 after he failed to consistently report to his probation officer, ruled after asking Chan whether he would "make a fool out...

  • The conclusions were included in an announcement Thursday from the House Ethics Committee that it was extending its review of the three-term congressman, an early and strong supporter of President Donald Trump. Collins, who has denied any wrongdoing, was the largest shareholder of Australia's Innate Immunotherapeutics Limited and sat on the company's...

  • VAL-DE-REUIL, France, Oct 12- Sanofi on Thursday expressed confidence in the growth of its influenza vaccines after committing to invest 170 million euros to expand its manufacturing facility at Val-de-Reuil in north-western France. Annual flu epidemics cause three to five million cases of severe illness worldwide and 250,000-500,000 deaths, according...

  • Oct 12- The Trump Administration threw its support behind a public-private partnership with 11 drug companies to advance a new class of drugs that uses the body's immune system to fight cancer. The Partnership for Accelerating Cancer Therapies or PACT will devote $215 million to identify and test chemical signatures in the body that will help predict which...

  • Oct 12- The Trump Administration threw its support behind a public-private partnership with 11 drug companies to advance a new class of drugs that uses the body's immune system to fight cancer. The Partnership for Accelerating Cancer Therapies or PACT will devote $215 million to identify and test chemical signatures in the body that will help predict which...

  • The panel experts to the Food and Drug Administration voted unanimously in favor of Spark Therapeutics' injectable therapy, which aims to improve vision by replacing a defective gene needed to process light. The FDA has until mid-January to make its decision and does not have to follow the panel's recommendation, though it often does. While the therapy from...

  • Oct 12- The National Institutes of Health said on Thursday it had partnered 11 biopharma companies to help advance a new class of drugs that uses the body's immune system to fight cancer. The five-year public-private research collaboration, called Partnership for Accelerating Cancer Therapies, includes drugmakers AbbVie, Roche Holding AG and...

  • ZURICH, Oct 12- Landmark Roche patents that helped launch the modern biotechnology era end next year, extinguishing a source of billions of dollars in income for the Swiss drugmaker and piling pressure on its new medicines to succeed. In 2018 alone, experts estimate the patents will reap $1 billion for Roche and California's City of Hope medical centre, where the...

  • PARIS, Oct 12- Sanofi will invest 170 million euros to expand its vaccines manufacturing site at Val-de-Reuil in north-western France, in a drive aimed at boosting the production of one of its influenza vaccines. "Influenza continues be a major public health problem around the world, causing serious complications, hospitalizations and deaths, mostly for...

  • In a story Oct. 9 about an experimental gene therapy for blindness, The Associated Press erroneously reported the deadline for a decision by the U.S. Food and Drug Administration. Seeing hope: FDA panel considers gene therapy for blindness. Advisers to the U.S. Food and Drug Administration will meet Thursday to consider whether to recommend approval of a gene...

  • CHICAGO, Oct 4- A DNA-based Zika vaccine from Inovio Pharmaceuticals Inc and South Korea's GeneOne Life Science Inc induced anti-Zika immune responses in an early stage human trial, U.S. researchers reported on Wednesday. Unlike conventional vaccines, which often use inactivated or killed versions of a virus, the Inovio-GeneOne shot is a synthetic vaccine...

  • LONDON, Oct 3- A seasonal flu vaccine that would be the first in the world to fight all types of the virus is to be tested in a two-year clinical trial involving more than 2,000 patients by researchers in Oxford. The so-called universal vaccine was developed by Oxford University's Jenner Institute and Vaccitech, a spin-out biotech company founded by Jenner...

  • CHICAGO, Sept 29- The U.S. government is investing more than $170 million to help two new vaccines against the Ebola virus and two Ebola drugs complete the steps needed for approval from the Food and Drug Administration. The Biomedical Advanced Research and Development Authority, part of the department of Health and Human Services, said on Friday it would buy the...

  • PARIS, Sept 28- The European Commission approved Regeneron Pharmaceuticals' and Sanofi's key biologic treatment dupilumab for moderate-to-severe atopic dermatitis, the two companies said on Thursday. The move comes after the U. S Food and Drug Administration regulator had also approved the injectable antibody drug in March. Analysts on average expect...